EUVIMEDEUVIMED entdecken
Open Access

Resveratrol Mitigates Uremic Toxin-Induced Intestinal Barrier Dysfunction in Chronic Kidney Disease by Promoting Mitophagy and Inhibiting Apoptosis Pathways

Cai-Mei Zheng, Yi-Chou Hou, Kuo-Wang Tsai, Wan-Chung Hu, Hsiu-Chien Yang, Min-Tser Liao, Kuo-Cheng Lu

International Journal of Medical Sciences · 2024 · 21 (13) · 2437-2449

DOI: 10.7150/ijms.100963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2024. Verfasst von Cai-Mei Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan. Hauptthemen laut MEDLINE: Resveratrol, Renal Insufficiency, Chronic, Mitophagy, Apoptosis. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolRenal Insufficiency, ChronicMitophagyApoptosisIntestinal MucosaIndicanAnimalsMiceUremic ToxinsHumansSignal TransductionMaleDisease Models, Animal

Stichwörter der Autor:innen

apoptosisautophagyindoxyl sulfateintestinal barriermitophagyresveratroltight junction proteins

Substanzen

ResveratrolIndicanUremic Toxins

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • TMU Research Centre of Urology and Kidney, Taipei Medical University, Taipei, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Cardinal Tien Hospital, School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
  • Department of Medical Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
  • Department of Clinical Pathology and Medical Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan.

Zitieren

APA

Zheng, C. M., Hou, Y. C., Tsai, K. W., Hu, W. C., Yang, H. C., Liao, M. T., & Lu, K. C. (2024). Resveratrol Mitigates Uremic Toxin-Induced Intestinal Barrier Dysfunction in Chronic Kidney Disease by Promoting Mitophagy and Inhibiting Apoptosis Pathways. International Journal of Medical Sciences, 21(13), 2437-2449. https://doi.org/10.7150/ijms.100963

Vancouver

Zheng CM, Hou YC, Tsai KW, Hu WC, Yang HC, Liao MT, et al. Resveratrol Mitigates Uremic Toxin-Induced Intestinal Barrier Dysfunction in Chronic Kidney Disease by Promoting Mitophagy and Inhibiting Apoptosis Pathways. International Journal of Medical Sciences. 2024;21(13):2437-2449. doi:10.7150/ijms.100963

BibTeX
@article{Zheng2024,
  author = {Zheng, Cai-Mei and Hou, Yi-Chou and Tsai, Kuo-Wang and Hu, Wan-Chung and Yang, Hsiu-Chien and Liao, Min-Tser and Lu, Kuo-Cheng},
  title = {Resveratrol Mitigates Uremic Toxin-Induced Intestinal Barrier Dysfunction in Chronic Kidney Disease by Promoting Mitophagy and Inhibiting Apoptosis Pathways},
  journal = {International Journal of Medical Sciences},
  year = {2024},
  volume = {21},
  number = {13},
  pages = {2437--2449},
  doi = {10.7150/ijms.100963}
}
Kostenlos starten →